Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He wasn’t the one presenting. It was a world leading expert in the field, Dars Aarsland
Mind explaining what it is I'm supposed to see? I have to admit I keep looking at your options posts but I'm totally lost.
thanks
When is quarterly due?
Thanks for reaching out and sharing.
IR said PA on the front burner or your interpretation?
I’m thinking more along the lines of the following week.
This week is the dog and poney show, get some investors to buy in before the pop, reduce the amount of shares available or at least more eyes on us. Then the following week come out with results.
Cause on the spanish trial registry it says ended early june. Can’t remember the exact date.
I like the top line readout expected by June part.
What podcast?
I wonder what the title for Monday’s presentation is? Strange that it’s not on the menu.
Thanks for this post, your insights are valuable as always.
For the uninitiated, who is this JC guy?
Snooze fest, geez
Glad to see you back.
Warmest wishes
Jay
It wasn’t there on monday.
It’s the addition of the extension to the PDD trial
there is some change on the spanish clinical site…
https://reec.aemps.es/reec/public/detail.html
probably some minor update glitch, but strange timing.
Why is there no mention of the Rett success/progress in this press release?
Wouldn't you want to have it mentionned in the section about Anavex?
Damn they need a better PR firm!
great find George
I like this part in regards with next week's conference
Shark Tank
One exciting feature of the conference is the Epilepsy Foundation Shark Tank Competition, which will be held on Thursday, May 23. This annual competition invites researchers, scientists, entrepreneurs, and more to submit their innovative new ideas in seizure treatment and care for people living with epilepsy. A panel of judges then select a series of finalists who are invited to present their product concepts or candidates at the AEDD Trials Conference.
The winning entry (or entries) will be selected through live voting by conference attendees and a panel of judges (Sharks) representing physicians and scientists, corporate executives, leading industry investors, people with epilepsy, and advocates. The winner(s) will receive international recognition and compete for awards totaling $200,000 to support the development and commercialization of an important new product, technology, or therapeutic concept to help people with epilepsy. Learn about the 2018 Shark
https://www.epilepsy.com/make-difference/research-and-new-therapies/engagement/conferences/antiepileptic-drug-trials-xv
Did you guys just have a reading party... 3 different posts on the same paper within minutes
I like the new corporate presentation, seems more professionnal then past ones and easier to understand for a non scientific person.
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
Nice post!
I'm confused... why does it say that it's beginning? I thought it started last year.
If it's just starting, does this mean we reached 50% enrollement / full enrollement or something different?
Hi Bio I always appreciate your insight,
Any thoughts on Anavex's radio silence since then?
thanks
Hi Xena, mind explaining how this poison pill would work?
What’s RISP?
Well said.
When is the Kaminsky event?
Whats the event in 15 days?
So far three buys for respectively
1650, 1500 and 1450, looks like a count down to me.
I know we keep thinking Biogen, but could we be the reason Pfizer raised 4 billion?
http://finance.yahoo.com/news/pfizer-prices-4-000-000-235300183.html
And, what did it say?
What's with the volume today
Care to elaborate on the visions from your crystal ball?
Is this a guess or based on past experience?
Is this increase related to the stock options exercised?